Suppr超能文献

纤维肌痛症——有新的治疗方法吗?

"Fibromyalgia - are there any new approaches?".

机构信息

Rheumatologist, Full professor of Department of Clinic, Pontifícia Universidade Católica de São Paulo, Member of the Fibromyalgia, Pain and other Soft Tissue Syndromes Comission, Brazilian Society of Rheumatology, Brazil.

Rheumatology, Habilitation at Pain Area, Member of the Fibromyalgia, Pain and other Soft Tissue Syndromes Comission, Brazilian Society of Rheumatology, Brazil.

出版信息

Best Pract Res Clin Rheumatol. 2024 Mar;38(1):101933. doi: 10.1016/j.berh.2024.101933. Epub 2024 Feb 13.

Abstract

INTRODUCTION

Approaching patients with fibromyalgia (FM) is challenging due to the limited availability of scientifically proven effective therapies.

OBJECTIVE

Review the treatments in use for FM and present new knowledge that could benefit these patients. Non-pharmacological interventions are recommended as the first line of treatment: aerobic exercise, cognitive behavioral therapy and patient education, all aimed at improving pain and other symptoms. Additional approaches have been studied, such as, digital health interventions, combined treatments, noninvasive neuromodulation, and others. Concerning pharmacological therapy, the mechanism of action of the medications currently used is to promote pain modulation. Medications approved by Food and Drug Administration are duloxetine, milnacipran and pregabalin. Amitriptyline, cyclobenzaprine, gabapentin and naltrexone are considered for off-label use. Cannabinoids, vitamin D supplementation are still controversial and further research is needed.

CONCLUSION

The combination of therapies, whether old, recent or reformulated, are the most effective strategy for managing symptoms in patients with fibromyalgia.

KEY WORDS

fibromyalgia, treatment, nonpharmacological interventions, pharmacological treatment.

摘要

简介

由于科学证明有效的治疗方法有限,因此治疗纤维肌痛(FM)患者具有挑战性。

目的

回顾用于 FM 的治疗方法,并介绍可能使这些患者受益的新知识。建议将非药物干预作为一线治疗方法:有氧运动、认知行为疗法和患者教育,所有这些都旨在改善疼痛和其他症状。已经研究了其他方法,例如数字健康干预、联合治疗、非侵入性神经调节等。关于药物治疗,目前使用的药物的作用机制是促进疼痛调节。美国食品和药物管理局批准的药物有度洛西汀、米那普仑和普瑞巴林。阿米替林、环苯扎林、加巴喷丁和纳曲酮被认为是标签外使用。大麻素、维生素 D 补充剂仍存在争议,需要进一步研究。

结论

无论是旧的、新的还是重新配方的治疗方法的组合,都是管理纤维肌痛患者症状的最有效策略。

关键词

纤维肌痛、治疗、非药物干预、药物治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验